Lioresal

Baclofen, the active ingredient in Lioresal, is a muscle relaxant presented as an oral dosage form for oral use. It is employed to reduce spasticity associated with neurological disorders such as multiple sclerosis and cerebral palsy.

GNH USA supplies Lioresal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution, ensuring timely delivery across multiple regulatory regions.

Lioresal (baclofen) acts on the central nervous system to alleviate abnormal muscle tone in various spasticity‑related conditions.

- Multiple sclerosis spasticity: reduces muscle stiffness and improves mobility in affected patients. - Cerebral palsy spasticity: lessens involuntary muscle contractions and enhances functional movement. - General spasticity: decreases tone and frequency of spasms in diverse neurological disorders.

Baclofen may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Drowsiness: increased sleepiness, especially after dose initiation. - Weakness: reduced muscular strength, often transient. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Seizures: convulsive episodes requiring immediate medical attention. - Hallucinations: visual or auditory disturbances. - Respiratory depression: slowed breathing that may be life‑threatening.

When prescribing baclofen, clinicians should consider several safety measures.

- Renal function: monitor in patients with renal impairment. - Hepatic function: adjust dose in severe liver disease. - Discontinuation: avoid abrupt cessation to prevent withdrawal symptoms. - Elderly: start with lower dose and titrate cautiously. - Hypersensitivity: contraindicated in patients with known baclofen allergy. - Store at room temperature: keep in the original pack, protect from moisture.

Baclofen can interact with other medicines, requiring careful assessment.

Major Interactions (Avoid): - Alcohol: additive central nervous system depression. - Opioids: increased sedation and risk of respiratory depression. - Carbamazepine: may reduce baclofen plasma concentrations.

Moderate Interactions (Monitor Closely): - Antihypertensives: potential enhancement of hypotensive effect. - Rifampin (CYP450 inducer): may decrease baclofen exposure.